Cerebral malaria pathogenesis: Dissecting the role of CD4⁺ and CD8⁺ T-cells as major effectors in disease pathology

References

• Kataria P, Surela N, Chaudhary A, Das J. MiRNA: biological regulator in host-parasite interaction during malaria infection. Int J Environ Res Public Health. 2022;19(4):2395. doi:10.3390/ijerph19042395.
   PubMed Web of Science ®Google Scholar
• Talapko J, Škrlec I, Alebić T, Jukić M, Včev A. Malaria: the past and the present. Microorganisms. 2019;7(6):179. doi:10.3390/microorganisms7060179.
   PubMed Web of Science ®Google Scholar
• van der Pluijm RW, Tripura R, Hoglund RM, Tracking Resistance to Artemisinin Collaboration., et al. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet. 2018;395(10233):1345–1360. doi:10.1016/S0140-6736(20)30552-3.
   Web of Science ®Google Scholar
• Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat Rev Dis Primers. 2017;3(1):17050. doi:10.1038/nrdp.2017.50.
   PubMedGoogle Scholar
• Organization WH. World Malaria Report 2023. Geneva: World Health Organization; 2023.
   Google Scholar
• Nanfack CN, Bilong Y, Kagmeni G, Nathan NN, Bella LA. Malarial retinopathy in adult: a case report. Pan Afr Med J. 2017;27:224. doi:10.11604/pamj.2017.27.224.11026.
   PubMedGoogle Scholar
• World Health Organization, Geneva, 2021.
   Google Scholar
• Bruneel F. Human cerebral malaria: 2019 mini review. Rev Neurol (Paris). 2019;175(7–8):445–450. doi:10.1016/j.neurol.2019.07.008.
   PubMed Web of Science ®Google Scholar
• Luzolo AL, Ngoyi DM. Cerebral malaria. Brain Res Bull. 2019;145:53–58. doi:10.1016/j.brainresbull.2019.01.010.
   PubMed Web of Science ®Google Scholar
• John CC, Bangirana P, Byarugaba J, et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics. 2008;122(1):e92–e99. doi:10.1542/peds.2007-3709.
   PubMed Web of Science ®Google Scholar
• Birbeck GL, Molyneux ME, Kaplan PW, et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol. 2010;9(12):1173–1181. doi:10.1016/S1474-4422(10)70270-2.
   PubMed Web of Science ®Google Scholar
• Olliaro P. Mortality associated with severe Plasmodium falciparum malaria increases with age. Clin Infect Dis. 2008;47(2):158–160. doi:10.1086/589288.
   PubMed Web of Science ®Google Scholar
• Prakash MA, Stein G. Malaria presenting as atypical depression. Br J Psychiatry. 1990;156(4):594–595. doi:10.1192/s000712500017905x.
   PubMedGoogle Scholar
• Kochar, D K, Kumawat, B L, Thanvi, I, Joshi, A, Vyas, S P, Shubhakaran,. Ophthalmoscopic abnormalities in adults with falciparum malaria. QJM 1998;91(12):845–852. doi:10.1093/qjmed/91.12.845.
   PubMed Web of Science ®Google Scholar
• Sahu PK, Hoffmann A, Majhi M, et al. Brain magnetic resonance imaging reveals different courses of disease in pediatric and adult cerebral malaria. Clin Infect Dis. 2021;73(7):e2387–e2396. doi:10.1093/cid/ciaa1647.
   PubMed Web of Science ®Google Scholar
• Idro R, Otieno G, White S, et al. Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria. Malar J. 2005;4(1):57. doi:10.1186/1475-2875-4-57.
   PubMedGoogle Scholar
• Wassmer SC, Taylor TE, Rathod PK, et al. Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am J Trop Med Hyg. 2015;93(3 Suppl):42–56. doi:10.4269/ajtmh.14-0841.
   PubMed Web of Science ®Google Scholar
• Genton B, Al-Yaman F, Alpers M, Mokela D. Indicators of fatal outcome in paediatric cerebral malaria: a study of 134 comatose Papua New Guinean children. Int J Epidemiol. 1997;26(3):670–676. doi:10.1093/ije/26.3.670.
   PubMed Web of Science ®Google Scholar
• Crawley J, Smith S, Muthinji P, Marsh K, Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child. 2001;84(3):247–253. doi:10.1136/adc.84.3.247.
   PubMed Web of Science ®Google Scholar
• Song X, Wei W, Cheng W, et al. Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Front Cell Infect Microbiol. 2022;12:939532. doi:10.3389/fcimb.2022.939532.
   PubMed Web of Science ®Google Scholar
• Brodeur KRN, Herculano A, Oliveira K. Clinical aspects of malarial retinopathy: a critical, 2022.
   Google Scholar
• Idro R, Carter JA, Fegan G, Neville BG, Newton CR. Risk factors for persisting neurological and cognitive impairments following cerebral malaria. Arch Dis Child. 2006;91(2):142–148. doi:10.1136/adc.2005.077784.
   PubMed Web of Science ®Google Scholar
• Schiess N, Villabona-Rueda A, Cottier KE, Huether K, Chipeta J, Stins MF. Pathophysiology and neurologic sequelae of cerebral malaria. Malar J. 2020;19(1):266. doi:10.1186/s12936-020-03336-z.
   PubMed Web of Science ®Google Scholar
• Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68(4):267–274. doi:10.1203/PDR.0b013e3181eee738.
   PubMed Web of Science ®Google Scholar
• Opoka RO, Xia Z, Bangirana P, John CC. Inpatient mortality in children with clinically diagnosed malaria as compared with microscopically confirmed malaria. Pediatr Infect Dis J. 2008;27(4):319–324. doi:10.1097/INF.0b013e31815d74dd.
   PubMed Web of Science ®Google Scholar
• Mason DP, Kawamoto F, Lin K, Laoboonchai A, Wongsrichanalai C. A comparison of two rapid field immunochromatographic tests to expert microscopy in the diagnosis of malaria. Acta Trop. 2002;82(1):51–59. doi:10.1016/s0001-706x(02)00031-1.
   PubMed Web of Science ®Google Scholar
• Taylor BJ, Lanke K, Banman SL, et al. A direct from blood reverse transcriptase polymerase chain reaction assay for monitoring falciparum malaria parasite transmission in elimination settings. Am J Trop Med Hyg. 2017;97(2):533–543. doi:10.4269/ajtmh.17-0039.
   PubMed Web of Science ®Google Scholar
• Beare NA, Lewallen S, Taylor TE, Molyneux ME. Redefining cerebral malaria by including malaria retinopathy. Future Microbiol. 2011;6(3):349–355. doi:10.2217/fmb.11.3.
   PubMed Web of Science ®Google Scholar
• Varo R, Crowley VM, Sitoe A, et al. Adjunctive therapy for severe malaria: a review and critical appraisal. Malar J. 2018;17(1):47. doi:10.1186/s12936-018-2195-7.
   PubMed Web of Science ®Google Scholar
• Sahu PK, Mohanty S. Pathogenesis of cerebral malaria: new trends and insights for developing adjunctive therapies. Pathogens. 2023;12(4):522. doi:10.3390/pathogens12040522.
   PubMed Web of Science ®Google Scholar
• De Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137(5):755–772. doi:10.1017/S0031182009991715.
   PubMed Web of Science ®Google Scholar
• De Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002;4(3):291–300. doi:10.1016/s1286-4579(02)01541-1.
   PubMed Web of Science ®Google Scholar
• Smith CD, Brown AE, Nakazawa S, Fujioka H, Aikawa M. Multi-organ erythrocyte sequestration and ligand expression in rhesus monkeys infected with Plasmodium coatneyi malaria. Am J Trop Med Hyg. 1996;55(4):379–383. doi:10.4269/ajtmh.1996.55.379.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Fujioka H, Luc KD, et al. A correlation of the sequestration rate of Plasmodium coatneyi-infected erythrocytes in cerebral and subcutaneous tissues of a rhesus monkey. Am J Trop Med Hyg. 1996;55(3):311–314. doi:10.4269/ajtmh.1996.55.311.
   PubMed Web of Science ®Google Scholar
• Fujioka H, Millet P, Maeno Y, et al. A nonhuman primate model for human cerebral malaria: rhesus-monkeys experimentally infected with Plasmodium fragile. Exp Parasitol. 1994;78(4):371–376. doi:10.1006/expr.1994.1040.
   PubMed Web of Science ®Google Scholar
• Tongren JE, Yang C, Collins WE, Sullivan JS, Lal AA, Xiao L. Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg. 2000;62(4):530–534. doi:10.4269/ajtmh.2000.62.530.
   PubMed Web of Science ®Google Scholar
• Robert C, Peyrol S, Pouvelle B, Gay-Andrieu F, Gysin J. Ultrastructural aspects of Plasmodium falciparum-infected erythrocyte adherence to endothelial cells of Saimiri brain microvasculature. Am J Trop Med Hyg. 1996;54(2):169–177. doi:10.4269/ajtmh.1996.54.169.
   PubMed Web of Science ®Google Scholar
• Engwerda C, Belnoue E, Grüner AC, Rénia L. Experimental models of cerebral malaria. Immunol Immunopath Malaria. 2005:103–143.
   Google Scholar
• Thakur RS, Tiwari M, Chauhan R, et al. Mesenchymal stem cells reverse the pathophysiology of cerebral malaria induced by Plasmodium berghei ANKA, 2022.
   Google Scholar
• Strangward P, Haley MJ, Shaw TN, et al. A quantitative brain map of experimental cerebral malaria pathology. PLoS Pathog. 2017;13(3):e1006267. doi:10.1371/journal.ppat.1006267.
   PubMed Web of Science ®Google Scholar
• Basir R, Rahiman SF, Hasballah K, et al. Plasmodium berghei ANKA infection in ICR mice as a model of cerebral malaria. Iran J Parasitol. 2012;7(4):62.
   PubMed Web of Science ®Google Scholar
• Dorovini-Zis K, Schmidt K, Huynh H, et al. The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol. 2011;178(5):2146–2158. doi:10.1016/j.ajpath.2011.01.016.
   PubMed Web of Science ®Google Scholar
• Conroy AL, Phiri H, Hawkes M, et al. Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study. PLoS One. 2010;5(12):e15291. doi:10.1371/journal.pone.0015291.
   PubMed Web of Science ®Google Scholar
• Albuquerque M. Cytoadherence capabilities of Plasmodium berghei ANKA and NK65 infected red blood cells in different malaria models, 2011.
   Google Scholar
• Jensen AR, Adams Y, Hviid L. Cerebral Plasmodium falciparum malaria: the role of PfEMP1 in its pathogenesis and immunity, and PfEMP1-based vaccines to prevent it. Immunol Rev. 2020;293(1):230–252. doi:10.1111/imr.12807.
   PubMed Web of Science ®Google Scholar
• Qidwai T, Qidwai T. Vascular cell adhesion molecule-1 (VCAM-1) Polymorphisms. Explorat Host Genet Fact Associat Malaria. 2021:159–172.
   Google Scholar
• Ueno N, Lodoen MB. From the blood to the brain: avenues of eukaryotic pathogen dissemination to the central nervous system. Curr Opin Microbiol. 2015;26:53–59. doi:10.1016/j.mib.2015.05.006.
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Sharma A. Dissecting the mechanisms of pathogenesis in cerebral malaria. PLoS Pathog. 2022;18(11):e1010919. doi:10.1371/journal.ppat.1010919.
   PubMed Web of Science ®Google Scholar
• Wittchen ES. Endothelial signaling in paracellular and transcellular leukocyte transmigration. Front Biosci (Landmark Ed). 2009;14(7):2522–2545. doi:10.2741/3395.
   PubMedGoogle Scholar
• Darling TK, Mimche PN, Bray C, et al. EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria. PLoS Pathog. 2020;16(1):e1008261. doi:10.1371/journal.ppat.1008261.
   PubMed Web of Science ®Google Scholar
• Chaudhary A, Kataria P, Surela N, Das J. Pathophysiology of cerebral malaria: implications of MSCs as a regenerative medicinal tool. Bioengineering. 2022;9(6):263. doi:10.3390/bioengineering9060263.
   PubMedGoogle Scholar
• Bernabeu M, Smith JD. EPCR and malaria severity: the center of a perfect storm. Trends Parasitol. 2017;33(4):295–308. doi:10.1016/j.pt.2016.11.004.
   PubMed Web of Science ®Google Scholar
• Petersen JE, Lavstsen T, Craig A. Breaking down brain barrier breaches in cerebral malaria. J Clin Invest. 2016;126(10):3725–3727. doi:10.1172/JCI90188.
   PubMed Web of Science ®Google Scholar
• Punsawad C, Maneerat Y, Chaisri U, Nantavisai K, Viriyavejakul P. Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria. Malar J. 2013;12(1):260. doi:10.1186/1475-2875-12-260.
   PubMedGoogle Scholar
• Lopez-Ramirez MA, Reijerkerk A, De Vries HE, Romero IA. Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation. Faseb J. 2016;30(8):2662–2672. doi:10.1096/fj.201600435RR.
   PubMed Web of Science ®Google Scholar
• Barker KR, Lu Z, Kim H, et al. miR-155 modifies inflammation, endothelial activation and blood-brain barrier dysfunction in cerebral malaria. Mol Med. 2017;23(1):24–33. doi:10.2119/molmed.2016.00139.
   PubMedGoogle Scholar
• Riggle BA, Manglani M, Maric D, et al. CD8+ T cells target cerebrovasculature in children with cerebral malaria. J Clin Invest. 2020;130(3):1128–1138. doi:10.1172/JCI133474.
   PubMed Web of Science ®Google Scholar
• Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV. Potential role of MCP-1 in endothelial cell tight junctionopening’: signaling via Rho and Rho kinase. J Cell Sci. 2003;116(Pt 22):4615–4628. doi:10.1242/jcs.00755.
   PubMed Web of Science ®Google Scholar
• Barrera V, MacCormick IJC, Czanner G, et al. Neurovascular sequestration in paediatric P. falciparum malaria is visible clinically in the retina. Elife. 2018;7:e32208. doi:10.7554/eLife.32208.
   PubMed Web of Science ®Google Scholar
• Miu J, Mitchell AJ, Müller M, et al. Chemokine gene expression during fatal murine cerebral malaria and protection due to CXCR3 deficiency. J Immunol. 2008;180(2):1217–1230. doi:10.4049/jimmunol.180.2.1217.
   PubMed Web of Science ®Google Scholar
• Shrivastava SK, Dalko E, Delcroix-Genete D, Herbert F, Cazenave PA, Pied S. Uptake of parasite-derived vesicles by astrocytes and microglial phagocytosis of infected erythrocytes may drive neuroinflammation in cerebral malaria. Glia. 2017;65(1):75–92. doi:10.1002/glia.23075.
   PubMed Web of Science ®Google Scholar
• Armah H, Wired EK, Dodoo AK, Adjei AA, Tettey Y, Gyasi R. Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health. 2005;2(1):123–131. doi:10.3390/ijerph2005010123.
   PubMedGoogle Scholar
• Fairhurst RM, Bess CD, Krause MA. Abnormal PfEMP1/knob display on Plasmodium falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into malaria pathogenesis and protection. Microbes Infect. 2012;14(10):851–862. doi:10.1016/j.micinf.2012.05.006.
   PubMed Web of Science ®Google Scholar
• David PH, Handunnetti SM, Leech JH, Gamage P, Mendis KN. Rosetting: a new cytoadherence property of malaria-infected erythrocytes. Am J Trop Med Hyg. 1988;38(2):289–297. doi:10.4269/ajtmh.1988.38.289.
   PubMed Web of Science ®Google Scholar
• Handunnetti SM, David PH, Perera K, Mendis KN. Uninfected erythrocytes form” rosettes” around Plasmodium falciparum infected erythrocytes. Am J Trop Med Hyg. 1989;40(2):115–118. doi:10.4269/ajtmh.1989.40.115.
   PubMed Web of Science ®Google Scholar
• Mackinnon MJ, Walker PR, Rowe JA. Plasmodium chabaudi: rosetting in a rodent malaria model. Exp Parasitol. 2002;101(2-3):121–128. doi:10.1016/S0014-4894(03)00023-7.
   PubMed Web of Science ®Google Scholar
• Storm J, Jespersen JS, Seydel KB, et al. Cerebral malaria is associated with differential cytoadherence to brain endothelial cells. EMBO Mol Med. 2019;11(2):e9164. doi:10.15252/emmm.201809164.
   PubMed Web of Science ®Google Scholar
• Belachew EB. Immune response and evasion mechanisms of Plasmodium falciparum parasites. J Immunol Res. 2018;2018:6529681–6529686. doi:10.1155/2018/6529681.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Kalantari P, Fitzgerald KA, Golenbock DT. Innate sensing of malaria parasites. Nat Rev Immunol. 2014;14(11):744–757. doi:10.1038/nri3742.
   PubMed Web of Science ®Google Scholar
• Arroyo EN, Pepper M. B cells are sufficient to prime the dominant CD4+ Tfh response to Plasmodium infection. J Exp Med. 2019;217(2):e20190849. doi:10.1084/jem.20190849.
   Web of Science ®Google Scholar
• Long CA, Zavala F. Immune responses in malaria. Cold Spring Harb Perspect Med. 2017;7(8):a025577. doi:10.1101/cshperspect.a025577.
   PubMed Web of Science ®Google Scholar
• Del Portillo HA, Ferrer M, Brugat T, Martin-Jaular L, Langhorne J, Lacerda MV. The role of the spleen in malaria. Cell Microbiol. 2012;14(3):343–355. doi:10.1111/j.1462-5822.2011.01741.x.
   PubMed Web of Science ®Google Scholar
• Dunst J, Kamena F, Matuschewski K. Cytokines and chemokines in cerebral malaria pathogenesis. Front Cell Infect Microbiol. 2017;7:324. doi:10.3389/fcimb.2017.00324.
   PubMed Web of Science ®Google Scholar
• Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol. 2005;5(9):722–735. doi:10.1038/nri1686.
   PubMed Web of Science ®Google Scholar
• Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7(10):803–815. doi:10.1038/nri2171.
   PubMed Web of Science ®Google Scholar
• Viebig NK, Wulbrand U, Förster R, Andrews KT, Lanzer M, Knolle PA. Direct activation of human endothelial cells by Plasmodium falciparum-infected erythrocytes. Infect Immun. 2005;73(6):3271–3277. doi:10.1128/IAI.73.6.3271-3277.2005.
   PubMed Web of Science ®Google Scholar
• Kurup SP, Butler NS, Harty JT. T cell-mediated immunity to malaria. Nat Rev Immunol. 2019;19(7):457–471. doi:10.1038/s41577-019-0158-z.
   PubMed Web of Science ®Google Scholar
• Huggins MA, Johnson HL, Jin F, et al. Perforin expression by CD8 T cells is sufficient to cause fatal brain edema during experimental cerebral malaria. Infect Immun. 2017;85(5). doi:10.1128/iai.00985-16.
   PubMed Web of Science ®Google Scholar
• Howland SW, Poh CM, Gun SY, et al. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol Med. 2013;5(7):984–999. doi:10.1002/emmm.201202273.
   PubMed Web of Science ®Google Scholar
• Haque A, Best SE, Unosson K, et al. Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J Immunol. 2011;186(11):6148–6156. doi:10.4049/jimmunol.1003955.
   PubMed Web of Science ®Google Scholar
• Baz A, Jackson DC, Kienzle N, Kelso A. Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design. Expert Rev Vaccines. 2005;4(5):711–723. doi:10.1586/14760584.4.5.711.
   PubMed Web of Science ®Google Scholar
• Reyes-Sandoval A, Wyllie DH, Bauza K, et al. CD8+ T effector memory cells protect against liver-stage malaria. J Immunol. 2011;187(3):1347–1357. doi:10.4049/jimmunol.1100302.
   PubMed Web of Science ®Google Scholar
• Belnoue E, Kayibanda M, Vigario AM, et al. On the pathogenic role of brain-sequestered αβ CD8+ T cells in experimental cerebral malaria. J Immunol. 2002;169(11):6369–6375. doi:10.4049/jimmunol.169.11.6369.
   PubMed Web of Science ®Google Scholar
• Swanson PA, Hart GT, Russo MV, et al. CD8+ T cells induce fatal brainstem pathology during cerebral malaria via luminal antigen-specific engagement of brain vasculature. PLoS Pathog. 2016;12(12):e1006022. doi:10.1371/journal.ppat.1006022.
   PubMed Web of Science ®Google Scholar
• Nie CQ, Bernard NJ, Norman MU, et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLoS Pathog. 2009;5(4):e1000369. doi:10.1371/journal.ppat.1000369.
   PubMed Web of Science ®Google Scholar
• Sorensen EW, Lian J, Ozga AJ, et al. CXCL10 stabilizes T cell–brain endothelial cell adhesion leading to the induction of cerebral malaria. JCI Insight. 2018;3(8). doi:10.1172/jci.insight.98911.
   Web of Science ®Google Scholar
• Howland SW, Poh CM, Rénia L. Activated brain endothelial cells cross-present malaria antigen. PLoS Pathog. 2015;11(6):e1004963. doi:10.1371/journal.ppat.1004963.
   PubMed Web of Science ®Google Scholar
• Eeka P, Phanithi PB. Cytotoxic T Lymphocyte Granzyme-b mediates neuronal cell death during Plasmodium berghei ANKA induced experimental cerebral malaria. Neurosci Lett. 2018;664:58–65. doi:10.1016/j.neulet.2017.11.021.
   PubMed Web of Science ®Google Scholar
• Vyas SP, Goswami R. A decade of Th9 cells: role of Th9 cells in inflammatory bowel disease. Front Immunol. 2018;9:1139. doi:10.3389/fimmu.2018.01139.
   PubMed Web of Science ®Google Scholar
• Jurewicz MM, Stern LJ. Class II MHC antigen processing in immune tolerance and inflammation. Immunogenetics. 2019;71(3):171–187. doi:10.1007/s00251-018-1095-x.
   PubMed Web of Science ®Google Scholar
• Lundie RJ, de Koning-Ward TF, Davey GM, et al. Blood-stage Plasmodium infection induces CD8+ T lymphocytes to parasite-expressed antigens, largely regulated by CD8α+ dendritic cells. Proc Natl Acad Sci U S A. 2008;105(38):14509–14514. doi:10.1073/pnas.0806727105.
   PubMed Web of Science ®Google Scholar
• Oakley MS, Sahu BR, Lotspeich-Cole L, et al. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria. J Immunol. 2013;191(9):4699–4708. doi:10.4049/jimmunol.1300396.
   PubMed Web of Science ®Google Scholar
• Yañez DM, Manning DD, Cooley AJ, Weidanz WP, Van Der Heyde H. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. Journal of Immunology (Baltimore, Md. 1950). 1996;157(4):1620–1624. doi:10.4049/jimmunol.157.4.1620.
   PubMed Web of Science ®Google Scholar
• Oh H, Ghosh S. NF-κB: roles and regulation in different CD 4+ T-cell subsets. Immunol Rev. 2013;252(1):41–51. doi:10.1111/imr.12033.
   PubMedGoogle Scholar
• Murphy KM, Stockinger B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol. 2010;11(8):674–680. doi:10.1038/ni.1899.
   PubMed Web of Science ®Google Scholar
• Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol. 2010;40(7):1830–1835. doi:10.1002/eji.201040391.
   PubMed Web of Science ®Google Scholar
• Perez-Mazliah D, Langhorne J. CD4 T-cell subsets in malaria: TH1/TH2 revisited. Front Immunol. 2015;5:671. doi:10.3389/fimmu.2014.00671.
   PubMed Web of Science ®Google Scholar
• Lazarevic V, Glimcher LH. T-bet in disease. Nat Immunol. 2011;12(7):597–606. doi:10.1038/ni.2059.
   PubMed Web of Science ®Google Scholar
• Walker JA, McKenzie AN. TH2 cell development and function. Nat Rev Immunol. 2018;18(2):121–133. doi:10.1038/nri.2017.118.
   PubMed Web of Science ®Google Scholar
• Oakley MS, Sahu BR, Lotspeich-Cole L, et al. T-bet modulates the antibody response and immune protection during murine malaria. Eur J Immunol. 2014;44(9):2680–2691. doi:10.1002/eji.201344437.
   PubMed Web of Science ®Google Scholar
• von der Weid T, Kopf M, Köhler G, Langhorne J. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol. 1994;24(10):2285–2293. doi:10.1002/eji.1830241004.
   PubMed Web of Science ®Google Scholar
• Langhorne J, Quin SJ, Sanni LA. Mouse models of blood-stage malaria infections: immune responses and cytokines involved in protection and pathology. Chem Immunol. 2002;80(80):204–228. doi:10.1159/000058845.
   PubMedGoogle Scholar
• Lönnberg T, Svensson V, James KR, et al. Single-cell RNA-seq and computational analysis using temporal mixture modeling resolves TH1/TFH fate bifurcation in malaria. Sci Immunol. 2017;2(9):eaal2192. doi:10.1126/sciimmunol.aal2192.
   PubMed Web of Science ®Google Scholar
• Amani V, Vigário A, Belnoue E, et al. Involvement of IFN-γ receptor-mediated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection. Eur J Immunol. 2000;30(6):1646–1655. doi:10.1002/1521-4141(200006)30:6<1646::AID-IMMU1646>3.0.CO;2-0.
   PubMed Web of Science ®Google Scholar
• Villegas-Mendez A, Greig R, Shaw TN, et al. IFN-γ–producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain. J Immunol. 2012;189(2):968–979. doi:10.4049/jimmunol.1200688.
   PubMed Web of Science ®Google Scholar
• Claser C, Malleret B, Gun SY, et al. CD8+ T cells and IFN-γ mediate the time-dependent accumulation of infected red blood cells in deep organs during experimental cerebral malaria. PLoS One. 2011;6(4):e18720. doi:10.1371/journal.pone.0018720.
   PubMed Web of Science ®Google Scholar
• Coomes SM, Pelly VS, Kannan Y, et al. IFNγ and IL-12 Restrict Th2 Responses during Helminth/Plasmodium Co-Infection and Promote IFNγ from Th2 Cells. PLoS Pathog. 2015;11(7):e1004994. doi:10.1371/journal.ppat.1004994.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang X-P, Hirahara K, O’Shea JJ. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol. 2011;32(9):395–401. doi:10.1016/j.it.2011.06.007.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu Z, Qin L, Wang T, Bai O. Insights into the mechanisms of Th17 differentiation and the Yin-Yang of Th17 cells in human diseases. Mol Immunol. 2021;134:109–117. doi:10.1016/j.molimm.2021.03.010.
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238. doi:10.1038/nature04753.
   PubMed Web of Science ®Google Scholar
• Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29(1):44–56. doi:10.1016/j.immuni.2008.05.007.
   PubMed Web of Science ®Google Scholar
• Zhao P, Li J, Tian Y, et al. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula. J Ethnopharmacol. 2018;217:152–162. doi:10.1016/j.jep.2018.02.023.
   PubMed Web of Science ®Google Scholar
• Egeberg A, Gisondi P, Carrascosa JM, Warren R, Mrowietz U. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis. J Eur Acad Dermatol Venereol. 2020;34(8):1695–1706. doi:10.1111/jdv.16273.
   PubMed Web of Science ®Google Scholar
• Keswani T, Bhattacharyya A. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Exp Parasitol. 2014;141:82–92. doi:10.1016/j.exppara.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Sarkar S, Keswani T, Sengupta A, Mitra S, Bhattacharyya A. Differential modulation of glial cell mediated neuroinflammation in Plasmodium berghei ANKA infection by TGF β and IL 6. Cytokine. 2017;99:249–259. doi:10.1016/j.cyto.2017.07.026.
   PubMed Web of Science ®Google Scholar
• Cipollini V, Anrather J, Orzi F, Iadecola C. Th17 and cognitive impairment: possible mechanisms of action. Front Neuroanat. 2019;13:95. doi:10.3389/fnana.2019.00095.
   PubMed Web of Science ®Google Scholar
• Scheinecker C, Göschl L, Bonelli M. Treg cells in health and autoimmune diseases: new insights from single cell analysis. J Autoimmun. 2020;110:102376. doi:10.1016/j.jaut.2019.102376.
   PubMed Web of Science ®Google Scholar
• Chauhan R, Awasthi V, Thakur RS, Pande V, Chattopadhyay D, Das J. CD4+ ICOS + Foxp3+: a sub-population of regulatory T cells contribute to malaria pathogenesis. Malar J. 2022;21(1):32. doi:10.1186/s12936-022-04055-3.
   PubMed Web of Science ®Google Scholar
• Pohar J, Simon Q, Fillatreau S. Antigen-specificity in the thymic development and peripheral activity of CD4+ FOXP3+ T regulatory cells. Front Immunol. 2018;9:1701. doi:10.3389/fimmu.2018.01701.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. cell. 2008;133(5):775–787. doi:10.1016/j.cell.2008.05.009.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-β signaling in the development of natural CD4+ CD25+ Foxp3+ regulatory T cells. Nat Immunol. 2008;9(6):632–640. doi:10.1038/ni.1607.
   PubMed Web of Science ®Google Scholar
• Cowman AF, Healer J, Marapana D, Marsh K. Malaria: biology and disease. Cell. 2016;167(3):610–624. doi:10.1016/j.cell.2016.07.055.
   PubMed Web of Science ®Google Scholar
• Sekiya T, Yoshimura A. In vitro Th differentiation protocol. TGF-β Signaling: Methods and Protocols. 2016:183–191.
   Google Scholar
• Rojas García C, Campos Mora M, Cárcamo I, et al. T regulatory cells-derived extracellular vesicles and their contribution to the generation of immune tolerance, 2020.
   Google Scholar
• Walther M, Jeffries D, Finney OC, et al. Distinct roles for FOXP3+ and FOXP3− CD4+ T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009;5(4):e1000364. doi:10.1371/journal.ppat.1000364.
   PubMed Web of Science ®Google Scholar
• Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog. 2010;6(4):e1000771. doi:10.1371/journal.ppat.1000771.
   PubMed Web of Science ®Google Scholar
• Steeg C, Adler G, Sparwasser T, Fleischer B, Jacobs T. Limited role of CD4+ Foxp3+ regulatory T cells in the control of experimental cerebral malaria. J Immunol. 2009;183(11):7014–7022. doi:10.4049/jimmunol.0901422.
   PubMed Web of Science ®Google Scholar
• Neurath MF, Kaplan MH. Th9 cells in immunity and immunopathological diseases. Semin Immunopathol. 2017;39(1):1–4. doi:10.1007/s00281-016-0611-z.
   PubMed Web of Science ®Google Scholar
• Dardalhon V, Awasthi A, Kwon H, et al. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells. Nat Immunol. 2008;9(12):1347–1355. doi:10.1038/ni.1677.
   PubMed Web of Science ®Google Scholar
• Kaplan MH. The Transcription Factor Network in Th9 Cells. Springer; 2017:11–20. doi:10.1007/s00281-016-0600-2.
   Google Scholar
• Licona-Limón P, Arias-Rojas A, Olguín-Martínez E. IL-9 and Th9 in parasite immunity. Semin Immunopathol. 2017;39(1):29–38. doi:10.1007/s00281-016-0606-9.
   PubMed Web of Science ®Google Scholar
• He Y, Dong L, Cao Y, Bi Y, Liu G. IL-9 and Th9 cells in tumor immunity. Tumor Microenviron Role Interleuk Part A. 2020:35–46.
   Google Scholar
• Shik D, Tomar S, Lee J-B, Chen C-Y, Smith A, Wang Y-H. IL-9-producing cells in the development of IgE-mediated food allergy. Semin Immunopathol. 2017;39(1):69–77. doi:10.1007/s00281-016-0605-x.
   PubMed Web of Science ®Google Scholar
• Elyaman W, Khoury SJ. Th9 cells in the pathogenesis of EAE and multiple sclerosis. Semin Immunopathol. 2017;39(1):79–87. doi:10.1007/s00281-016-0604-y.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Mukherjee S, Sengupta A, et al. CD4+ IL9+ (Th9) cells as the major source of IL-9, potentially modulate Th17/Treg mediated host immune response during experimental cerebral malaria. Mol Immunol. 2022;152:240–254. doi:10.1016/j.molimm.2022.11.005.
   PubMed Web of Science ®Google Scholar
• Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol. 2013;25(4):305–312. doi:10.1016/j.smim.2013.10.009.
   PubMed Web of Science ®Google Scholar
• Aqel S, Kraus E, Jena N, et al. Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development. Clin Exp Immunol. 2019;196(2):215–225. doi:10.1111/cei.13258.
   PubMed Web of Science ®Google Scholar
• Sengupta A, Keswani T, Sarkar S, Ghosh S, Mukherjee S, Bhattacharyya A. Autophagic induction modulates splenic plasmacytoid dendritic cell mediated immune response in cerebral malarial infection model. Microbes Infect. 2019;21(10):475–484. doi:10.1016/j.micinf.2019.05.004.
   PubMed Web of Science ®Google Scholar
• Organization WH. Guidelines for the Treatment of Malaria. Geneva: World Health Organization; 2015.
   Google Scholar
• Kouakou YI, Tod M, Leboucher G, et al. Systematic review of artesunate pharmacokinetics: implication for treatment of resistant malaria. Int J Infect Dis. 2019;89:30–44. doi:10.1016/j.ijid.2019.08.030.
   PubMed Web of Science ®Google Scholar
• Albrecht-Schgoer K, Lackner P, Schmutzhard E, Baier G. Cerebral malaria: current clinical and immunological aspects. Front Immunol. 2022;13:863568. doi:10.3389/fimmu.2022.863568.
   PubMed Web of Science ®Google Scholar
• Taylor TE, Molyneux ME. The pathogenesis of pediatric cerebral malaria: eye exams, autopsies, and neuroimaging. Ann N Y Acad Sci. 2015;1342(1):44–52. doi:10.1111/nyas.12690.
   PubMedGoogle Scholar
• Patel MM, Patel BM. Crossing the blood–brain barrier: recent advances in drug delivery to the brain. CNS Drugs. 2017;31(2):109–133. doi:10.1007/s40263-016-0405-9.
   PubMed Web of Science ®Google Scholar
• Tajes M, Ramos-Fernández E, Weng-Jiang X, et al. The blood-brain barrier: structure, function and therapeutic approaches to cross it. Mol Membr Biol. 2014;31(5):152–167. doi:10.3109/09687688.2014.937468.
   PubMed Web of Science ®Google Scholar
• Jiang X, Chen L, Zheng Z, et al. Synergistic effect of combined artesunate and tetramethylpyrazine in experimental cerebral malaria. ACS Infect Dis. 2020;6(9):2400–2409. doi:10.1021/acsinfecdis.0c00124.
   PubMed Web of Science ®Google Scholar
• Fasching P, Stradner M, Graninger W, Dejaco C, Fessler J. Therapeutic potential of targeting the Th17/Treg axis in autoimmune disorders. Molecules. 2017;22(1):134. doi:10.3390/molecules22010134.
   PubMed Web of Science ®Google Scholar
• Rts S. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386(9988):31–45.
   PubMed Web of Science ®Google Scholar
• Datoo MS, Dicko A, Tinto H, et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet. 2024;403(10426):533–544. doi:10.1016/S0140-6736(23)02511-4.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and role of regulatory T cells in rheumatoid arthritis. Front Immunol. 2021;12:626193. doi:10.3389/fimmu.2021.626193.
   PubMedGoogle Scholar
• Raimondo MG, Biggioggero M, Crotti C, Becciolini A, Favalli EG. Profile of sarilumab and its potential in the treatment of rheumatoid arthritis. Drug Des Devel Ther. 2017;11:1593–1603. doi:10.2147/DDDT.S100302.
   PubMed Web of Science ®Google Scholar
• Chauhan R, Tiwari M, Chaudhary A, Sharan Thakur R, Pande V, Das J. Chemokines: A key driver for inflammation in protozoan infection. Int Rev Immunol. 2023:1–18.
   Google Scholar